Skip to content

Evaluation of medication withdrawal in reducing the falls and fall risk in elderly Population on fall risk-increasing drugs

Deprescribing interventions ARMOR to reduce the risk of falls in Geriatric population on Fall Risk Increasing Drugs FRIDS An Open Label & Parallel group Randomized Controlled Trial - DeFRID trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/12/060516
Enrollment
526
Registered
2023-12-18
Start date
Unknown
Completion date
Unknown
Last updated
2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R54- Age-related physical debility

Interventions

Intervention1: ARMOR tool-based deprescribing intervention: ARMOR tool-based deprescribing intervention contains 5 steps- Assess, Review, Minimize, Optimize, Reassess. A clinical pharmacologist along

Sponsors

Indian Council of Medical Research
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients on 5 or more prescribed drugs with at least one FRIDs Ambulatory Willing to participate & give consent MoCA (Montreal Cognitive Assessment) with a score above 26 and can walk 10 meters or with a walking aid(walking stick, canes, callipers)

Exclusion criteria

Exclusion criteria: Critically ill patients, Patients with known neurological illnesses, cognitive impairment/ Dementia, Parkinsonism, stroke Elderly on homecare or special care Older adults using walkers, wheelchair

Design outcomes

Primary

MeasureTime frame
Frequency of falls Assessed by using Fall history questionnaire of McCrum 2020and fall efficacy scale Fall risks will be assessed by TUG & POMA Timepoint: Assessment at the base line & every 3 months till 1 year

Secondary

MeasureTime frame
Incremental cost effectiveness ratio (ICER) Timepoint: at the end of the study;Patient-reported outcomes- Quality of life based on EQ-5D- 5LTimepoint: at the base line & every 3 months till 1 year;Percentage of prescriptions that meet the World Health Organization (WHO) core drug use indicators at the end of the study- Rationality of prescriptions Timepoint: at the start & end of the study

Countries

India

Contacts

Public ContactRekha Priyadarshini

AIIMS Bibinagar, Hyderabad

dr.madhavieerike@gmail.com9941476332

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 6, 2026